Endometrial cancer is also known as uterine cancer, cancer of the corpus uteri, uterine corpus cancer, endometrical carcinoma.

It is the 6th most common malignancy worldwide.

Management of endometrial cancer should be divided based on risk, disease stage & patient's desire for fertility.

Endometrial%20cancer Signs and Symptoms


  • Also known as uterine cancer, cancer of the corpus uteri, uterine corpus cancer, endometrial carcinoma
  • The 6th most common malignancy worldwide
  • The most common gynecologic cancer in developed countries; 2nd most common in developing countries
  • More commonly presents in individuals >50 years of age
  • Usually diagnosed in its early stages and still localized, with high survival rates


  • Endometrial intraepithelial neoplasia (atypical endometrial hyperplasia) is the precursor lesion to endometrial cancer according to the 1994 World Health Organization (WHO) and International Endometrial Collaborative Group schemas
  • Papillary serous carcinoma accounts for 10% of cases, but comes with high mortality rates (40%)
  • Clear cell histologic type is rare (3%) but with poor prognosis

Risk Factors

  • Age ≥55 years
  • Excess estrogen (eg estrogen therapy, estrogen-producing tumors, early menarche, late menopause)
  • Obesity; high body mass index
  • Metabolic syndrome (eg hypertension, DM)
  • Nulliparity, infertility
  • Polycystic ovarian syndrome (PCOS)
  • Genetic mutation (eg hereditary non-polyposis colorectal cancer/Lynch syndrome)
  • Family history of endometrial cancer
  • Smoking

Prognostic Factors

  • Age
  • International Federation of Gynecology and Obstetrics (FIGO) stage
  • Depth of myometrial invasion
  • Tumor differentiation grade
  • Tumor type
  • Lymphovascular space invasion
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.
01 Sep 2020
Acute diarrhoea is the second leading cause of deathin children aged younger than 5 years, accounting forapproximately 1.9 million deaths worldwide each year;however, diarrhoea is a preventable and treatable condition.In Malaysia, acute gastroenteritis accounts for about 1.3%of all deaths in children aged younger than 5 years annually.Diarrhoea is defined as the passage of three or more looseor watery stools within 24 hours, and it may be clinicallycategorised as either acute watery diarrhoea (AWD), acutebloody diarrhoea, persistent diarrhoea or diarrhoea withsevere malnutrition.